Encouraging results from respiratory diseases vaccine trial
A biopharmaceutical company developing vaccines against infectious diseases has announced positive results for people with…
A biopharmaceutical company developing vaccines against infectious diseases has announced positive results for people with…
Cystic fibrosis has proved resistant to treatments that provide long-lasting respite from the sticky mucus…
Thanks to Covid-19 vaccines, messenger RNA (mRNA) technology has reached the mainstream. With a €23.4M…
Current treatments for cystic fibrosis are not suitable for all patients and have a limited…
Sanofi’s acquisition of its partner Translate Bio is a clear sign that pharmaceutical companies are…
Scientists in Sweden have found that some viruses can increase the buildup of protein ‘plaques’…
An inhaled drug from British company Verona Pharma has failed to significantly improve lung function…
Morphogen-IX, based in Cambridge, has raised €20.4M (£18.4M) to fund a new type of treatments…
It is bad news for asthma sufferers, as a UK biotech has abandoned the development…
ReViral will dedicate the funds to run two clinical trials to test whether its antiviral…
Enterprise Therapeutics has raised a substantial Series B financing round to bring its treatments for…
Danish biotech LEO Pharma started a Phase III trial in atopic dermatitis with an antibody…